Product Comparison

  Schering Plough 00052060202

No Image

McKesson # 706308 1166153
Description TICE® BCG Bladder Cancer Treatment Bacillus Calmette-Guérin (BCG) Live 50 mg Injection Single-Dose Vial 2 mL Bladder Cancer Treatment Valrubicin 40 mg / mL Injection Single-Dose Vial 5 mL
Manufacturer # 0005206020224201010104
Brand TICE® BCG 
Manufacturer Schering PloughHikma Specialty USA (Leucadia)
    Log In to Order   Log In to Order


Country of Origin United StatesUnknown
Generic Drug Code 1410394175
Generic Drug Name Bacillus Calmette-Guérin (BCG) LiveValrubicin
NDC Number 0005206020224201010104
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 days
Strength 50 mg40 mg / mL
UNSPSC Code 5120164751281810
Volume 2 mL5 mL
Application Bladder Cancer TreatmentBladder Cancer Treatment
Container Type Single-Dose VialSingle-Dose Vial
Dosage Form InjectionInjection
Storage Requirements Requires RefrigerationRequires Refrigeration
Type IntravesicalIntravesical
Features and Benefits
  • The dose for the intravesical treatment of carcinoma in situ and for the prophylaxis of recurrent papillary tumors consists of one vial of TICE® BCG suspended in 50 ml preservative-free saline
  • Intravesical TICE® BCG has been used as a therapy for, and prophylaxis against, recurrent tumors in patients with carcinoma in situ (CIS) of the urinary bladder, and to prevent recurrence of Stage TaT1 papillary tumors of the bladder at high risk of recurrence
  • BCG LIVE (TICE® BCG) is not a vaccine for the prevention of cancer
  • Reconstituted TICE® BCG should be kept refrigerated (2-8° C), protected from exposure to direct sunlight, and used within 2 hours
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Do not administer without diluting
  • For Intravesical use only
  • Not for intramuscular or intravenous use